Related Experiment Video
Updated: May 15, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
[Where does the development of new antituberculotics aim at?].
1Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové, Heyrovského 1203, 500 05 Hradec Králové, Ceská republika. waisser@faf.cuni.cz
Czech and Slovak scientists are developing novel antitubercular drugs. This review highlights recent advancements in antitubercular drug development from 2011-2012, aiding researchers and pharmaceutical professionals.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Context:
- Focus on antitubercular drug development in the Czech and Slovak Republics.
- Literature review of Chemical Abstracts from 2011 and early 2012.
Purpose:
- To provide a concise overview of recent antitubercular drug research.
- To assist scientists and pharmaceutical professionals in staying updated on new developments.
Summary:
- Presents a curated selection of nearly three thousand reports on antitubercular agents.
- Highlights key findings and trends in the field of antituberculotic research.
Impact:
- Facilitates knowledge transfer within the scientific community.
- Supports the ongoing efforts to combat tuberculosis through new drug discovery.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pharmacogenomics: Identification of New Drug Targets
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Anthelminthic Agents
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

